UNSPSC 51283214: Josamycin propionate

This classification denotes a macrolide antibiotic with the molecular formula C45H73NO16, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 053VA4B06Y, chemically known as leucomycin v, 3-acetate 4b-(3-methylbutanoate) 9-propanoate but more generally known as josamycin propionate, which bears US NIH Compound Identifier 5353696. European Medicines Agency schedules Josamycin propionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02814MIG.

UNSPSC 51283214 Josamycin propionate is a Commodity code that nominally designates a specific antibiotic active pharmaceutical ingredient, but recent state and local opportunities tagged under this code show minimal alignment with the code's scope. The most recent opportunities in the dataset reference pharmaceutical procurement activities — warehouse supply contracts for broad-spectrum antibiotics and naloxone — but do not reflect procurement of josamycin propionate specifically. State and local governments use related pharmaceutical Commodity codes to source finished-form medications, antibiotics, and emergency medical supplies through cooperative purchasing vehicles, typically via piggyback contracts through established pharmaceutical consortiums or through competitive bidding managed by county health departments and state public health agencies.

The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392) for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, with a total contract value of $2,999,999.11 over three years including renewal options. Seminole County, Florida issued an IFB (IFB60459723LAS) with a July 26, 2023 response deadline for 1,900 units of naloxone and 800 safe drug deactivation systems annually. The code shows activity across state health departments and county public health jurisdictions, primarily in Florida and Illinois. However, neither recent opportunity directly solicits josamycin propionate, suggesting the code sees limited state and local procurement activity under its specific pharmaceutical designation, or that opportunities in this product category are being tagged under broader pharmaceutical family or class codes rather than this specific commodity.